Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feinstein

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|February 13, 2025
CITE-Seq Analysis Reveals a Differential Natural Killer Cell <i>SPON2</i> Expression in Cardiovascular Disease Patients Impacted by Human-Cytomegalovirus Serostatus and DiabetesSujit Silas Armstrong, Daniel G Chen, Sunil Kumar, et al.
ESC Heart Failure|October 16, 2020
Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatmentHawkins C Gay, Arjun Sinha, Eriberto Michel, et al.
Medicine|August 16, 2021
Association between human immunodeficiency virus serostatus and the prevalence of atrial fibrillationNgozi Osuji, Sabina A Haberlen, Hiroshi Ashikaga, et al.
Circulation|June 4, 2019
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart AssociationMatthew J Feinstein, Priscilla Y Hsue, Laura A Benjamin, et al.
Health Affairs (Project Hope)|April 8, 2015
Older women with localized breast cancer: costs and survival rates increased across two time periodsAaron J Feinstein, Jessica Long, Pamela R Soulos, et al.
Open Heart|May 25, 2026
Acute effects of percutaneous coronary intervention on neutrophil activation and maturity markers in coronary and peripheral circulationReina Nagasaka, Harris Avgousti, Jessica Quaggin-Smith, et al.
Journal of the American Heart Association|November 12, 2025
Differential Performance of Polygenic Score for Coronary Artery Disease Based on Coronary Artery Calcium Between Men Living With and Without HIVGenevieve Wojcik, Marios Arvanitis, Sabina Haberlen, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
American Heart Journal|January 28, 2019
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected personsRobert A Riestenberg, Andrew Furman, Avery Cowen, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|February 13, 2025
CITE-Seq Analysis Reveals a Differential Natural Killer Cell <i>SPON2</i> Expression in Cardiovascular Disease Patients Impacted by Human-Cytomegalovirus Serostatus and DiabetesSujit Silas Armstrong, Daniel G Chen, Sunil Kumar, et al.
ESC Heart Failure|October 16, 2020
Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatmentHawkins C Gay, Arjun Sinha, Eriberto Michel, et al.
Medicine|August 16, 2021
Association between human immunodeficiency virus serostatus and the prevalence of atrial fibrillationNgozi Osuji, Sabina A Haberlen, Hiroshi Ashikaga, et al.
Circulation|June 4, 2019
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart AssociationMatthew J Feinstein, Priscilla Y Hsue, Laura A Benjamin, et al.
Health Affairs (Project Hope)|April 8, 2015
Older women with localized breast cancer: costs and survival rates increased across two time periodsAaron J Feinstein, Jessica Long, Pamela R Soulos, et al.
Open Heart|May 25, 2026
Acute effects of percutaneous coronary intervention on neutrophil activation and maturity markers in coronary and peripheral circulationReina Nagasaka, Harris Avgousti, Jessica Quaggin-Smith, et al.
Journal of the American Heart Association|November 12, 2025
Differential Performance of Polygenic Score for Coronary Artery Disease Based on Coronary Artery Calcium Between Men Living With and Without HIVGenevieve Wojcik, Marios Arvanitis, Sabina Haberlen, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
American Heart Journal|January 28, 2019
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected personsRobert A Riestenberg, Andrew Furman, Avery Cowen, et al.
Pageof 15